Wedbush maintained an Outperform on Anacor Pharmaceuticals (NASDAQ: ANAC) and raised its price target to $29.00 (from $20.00). Analyst Gregory ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE